Clinical trial
Prevention of Relapses in PR3-ANCA-associated Vasculitis, a Tailored Approach
NCT00128895 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prevention of Relapses in PR3-ANCA-associated Vasculitis, a Tailored Approach
- Lead sponsor
- University Medical Center Groningen
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- June 30, 2003
- Completion date
- December 31, 2014
- Enrollment
- 131 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.